Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

GSK Investigational Site
Andalusia Alabama 36420

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Andalusia Alabama

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site
Anniston Alabama

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

UAB Lung Health Center
Birmingham Alabama 35294

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Birmingham Alabama 35205

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

View More »

GSK Investigational Site
Birmingham Alabama 35294

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35242

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35209

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 3056
Birmingham Alabama 35209
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3836
Birmingham Alabama 35209
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Liposomal amikacin for inhalation and placebo to evaluate Pulmonary Nontuberculous Mycobacterial Lung Disease

Pearl Investigative Site
Florence Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 3438
Florence Alabama 35630
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3729
Foley Alabama 36535
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Huntsville Alabama 35801

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Investigative Site 3911
Huntsville Alabama 35801
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

1237.26.10620 Boehringer Ingelheim Investigational Site
Jasper Alabama
Updated

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Jasper Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 2423
Jasper Alabama 35501
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

GSK Investigational Site
Mobile Alabama 36608

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Mobile Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 4030
Mobile Alabama 36604
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Montgomery Alabama 36109

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Montgomery Alabama 36106

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Montgomery Alabama 36109

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Ozark Alabama 36360

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Pell City Alabama 35128

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Pisgah Alabama 35765

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Tuscumbia Alabama 35674

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Arizona

Novartis Investigative Site
Additional Locations Arizona

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 4015
Chandler Arizona 85224
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3731
Chandler Arizona 85224
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3164
Chandler Arizona 85224
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clinical Trial Connection
Flagstaff Arizona 86001

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

View More »

GSK Investigational Site
Flagstaff Arizona 86001

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Investigative Site 3904
Flagstaff Arizona 86001
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

GSK Investigational Site
Glendale Arizona 85306

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Novartis Investigative Site
Mesa Arizona 85205

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 4032
Mesa Arizona 85205
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pulmonary Associates P.A.
Phoenix Arizona 85006

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Phoenix Arizona

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Phoenix Arizona 85018

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Phoenix Arizona 85006

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Phoenix Arizona 85018

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Investigative Site 3135
Phoenix Arizona 85020
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 4003
Phoenix Arizona 85023
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last